AI in Health

Tempus AI is buying Personalis for roughly $1.5 billion, betting AI plus blood tests can spot cancer's return earlier. Wall...

A survey of 1,823 clinicians across 25 countries found five in six use AI with no employer policy, while most...

AI-powered drug discovery is revolutionizing pharmaceutical research in 2026. How machine learning accelerates target identification, molecular design,

An OpenAI Insider Bets Big on the Future of Medicine Another week, another eye-popping valuation coming out of the AI...

Researchers at DTU combined a quantum computer with generative AI to design novel peptides for vaccines, working on weekends with...

Artificial intelligence is rapidly transforming medical diagnostics, with 2026 marking a watershed year for FDA approvals and clinical deployment of...

Dutch hospitals are deploying AI systems that detect cancer earlier, reduce diagnostic wait times by 40%, and personalize treatment —...

AI is transforming pharmaceutical R&D in 2026, reducing drug discovery timelines by 40% and attracting billions in investment as the...

DeepMind's AlphaFold 3 is now integrated into drug discovery pipelines at Novartis, AstraZeneca, and Eli Lilly, cutting target-identification time from...

The UK passed a generational tobacco ban in 2026. Experts question if it will work, but the approach signals a...